haemophilus influenzae type b
Showing 1 - 25 of 85
Diphtheria, Tetanus, Pertussis Trial in Thai Binh (Hexaxim®)
Completed
- Diphtheria
- +5 more
- Hexaxim®
-
Thai Binh, VietnamPreventive Medicine Centre of Thai Binh Province
Mar 24, 2022
Acellular Pertussis, Hepatitis B, Haemophilus Influenzae Type b Trial in Dominican Republic, Finland (Infanrix hexa, Prevenar
Completed
- Acellular Pertussis
- +5 more
- Infanrix hexa
- +2 more
-
Santo Domingo, Distrito Nacional, Dominican Republic
- +15 more
Jul 3, 2020
Haemophilus Influenzae Type b, Neisseria Meningitidis, Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine Trial in
Completed
- Haemophilus Influenzae Type b
- +2 more
- Menitorix
- Infanrix IPV
-
Bydgoszcz, Poland
- +8 more
Jun 2, 2020
Whole Cell Pertussis, Haemophilus Influenzae Type b, Hepatitis B Trial in Bangkok, Khon Kaen, Songkla (Tritanrix-HepB/Hib-MenAC,
Completed
- Whole Cell Pertussis
- +5 more
- Tritanrix-HepB/Hib-MenAC
- +3 more
-
Bangkok, Thailand
- +2 more
Feb 17, 2020
Whole Cell Pertussis, Tetanus, Hepatitis B Trial in Muntinlupa, Bangkok (Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix,
Completed
- Whole Cell Pertussis
- +5 more
- Tritanrix-HepB/Hib-MenAC
- +2 more
-
Muntinlupa, Philippines
- +1 more
Feb 17, 2020
Acellular Pertussis, Haemophilus Influenzae Type b, Tetanus Trial in Hai Phong (Infanrix-IPV+Hib™)
Completed
- Acellular Pertussis
- +5 more
- Infanrix-IPV+Hib™
-
Hai Phong, VietnamGSK Investigational Site
Jan 3, 2020
Tetanus, Diphtheria, Haemophilus Influenzae Type b Trial in Poland (GSK2202083A vaccine, Infanrix hexa™, Menjugate™)
Completed
- Tetanus
- +6 more
- GSK2202083A vaccine
- +4 more
-
Bydgoszcz, Poland
- +8 more
Jan 3, 2020
Diphtheria, Hepatitis B, Acellular Pertussis Trial in Worldwide (Infanrix hexa)
Completed
- Diphtheria
- +6 more
- Infanrix hexa
-
Carlton, Victoria, Australia
- +28 more
Dec 26, 2019
Tetanus, Diphtheria, Haemophilus Influenzae Type b Trial in Poland (GSK2202083A vaccine, 10-valent pneumococcal vaccine (GSK
Completed
- Tetanus
- +6 more
- GSK2202083A vaccine
- +3 more
-
Bydgoszcz, Poland
- +8 more
Dec 31, 2019
Diphtheria, Tetanus, Poliomyelitis Trial in Singapore (GSK Biologicals' combined DTPa-IPV/Hib vaccine)
Completed
- Diphtheria
- +5 more
- GSK Biologicals' combined DTPa-IPV/Hib vaccine
-
Singapore, SingaporeGSK Investigational Site
Dec 26, 2019
Hepatitis B, Tetanus, Poliomyelitis Trial in Edmonton, Vancouver, Truro (Infanrix™ hexa)
Completed
- Hepatitis B
- +5 more
- Infanrix™ hexa
-
Edmonton, Alberta, Canada
- +2 more
Nov 15, 2019
Poliomyelitis, Tetanus, Acellular Pertussis Trial in Korea, Republic of (Infanrix™-IPV+Hib, Infanrix™ IPV, Hiberix™)
Completed
- Poliomyelitis
- +4 more
- Infanrix™-IPV+Hib
- +4 more
-
Daegu, Korea, Republic of
- +10 more
Nov 15, 2019
Poliomyelitis, Diphtheria, Haemophilus Influenzae Type b Trial in United States (Infanrix hexa, Pediarix, ActHIB)
Completed
- Poliomyelitis
- +5 more
- Infanrix hexa
- +8 more
-
Tucson, Arizona
- +42 more
Nov 15, 2019
Haemophilus Influenzae Type b, Tetanus, Hepatitis B Trial in Muntinlupa (GSK2036874A vaccine, Zilbrix™/Hib vaccine, Poliorix™)
Completed
- Haemophilus Influenzae Type b
- +5 more
- GSK2036874A vaccine
- +2 more
-
Muntinlupa, PhilippinesGSK Investigational Site
Sep 17, 2019
Diphtheria, Tetanus, Pertussis Trial in Russian Federation (Infanrix-IPV/Hib)
Completed
- Diphtheria
- +4 more
- Infanrix-IPV/Hib
-
Barnaul, Russian Federation
- +4 more
Sep 12, 2019
Diphtheria, Tetanus, Pertussis Trial in Hung Yen (Study subjects will be vaccinated with 3 (three) vaccine doses. The first
Completed
- Diphtheria
- +4 more
- Study subjects will be vaccinated with 3 (three) vaccine doses. The first vaccine will be administered intramuscularly starting at 6-12 weeks of age followed by two doses at four-week interval
-
Hung Yen, VietnamHung Yen, Kim Dong
May 1, 2019
Neisseria Meningitidis, Haemophilus Influenzae Type b Trial in United States (Hib-MenCY-TT (MenHibrix®), Pediarix®, Rotarix®)
Completed
- Neisseria Meningitidis
- Haemophilus Influenzae Type b
- Hib-MenCY-TT (MenHibrix®)
- +5 more
-
Birmingham, Alabama
- +25 more
Aug 16, 2018
Haemophilus Influenzae Type b, Neisseria Meningitidis Trial in North Adelaide, Carlton, Subiaco (Hib-MenCY-TT vaccine
Completed
- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- Hib-MenCY-TT vaccine (MenHibrix)
- +6 more
-
North Adelaide, South Australia, Australia
- +2 more
Jul 26, 2018
Haemophilus Influenzae Type b, Neisseria Meningitidis Trial in Spain (Menitorix™, Infanrix™ penta, Prevenar™)
Completed
- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- Menitorix™
- +3 more
-
Barcelona, Spain
- +7 more
Jul 26, 2018
Haemophilus Influenzae Type b, Neisseria Meningitidis Trial in Belgium, Germany (Hib-MenCY-TT vaccine, Hib-MenC-TT vaccine,
Completed
- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- Hib-MenCY-TT vaccine
- +4 more
-
Asse, Belgium
- +25 more
Jul 26, 2018
Haemophilus Influenzae Type b Trial (Hib conjugate vaccine)
Completed
- Haemophilus Influenzae Type b
- Hib conjugate vaccine
- (no location specified)
Aug 23, 2018
Haemophilus Influenzae Type b, Neisseria Meningitidis Trial in Australia, Mexico, United States (GSK Biologicals' Haemophilus
Completed
- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine
- +6 more
-
Birmingham, Alabama
- +92 more
Jul 26, 2018
Haemophilus Influenzae Type b, Neisseria Meningitidis Trial in Australia (Haemophilus influenzae type b and meningococcal
Completed
- Haemophilus Influenzae Type b
- Neisseria Meningitidis
- Haemophilus influenzae type b and meningococcal serogroup C (vaccine)
- +3 more
-
Garran, Australian Capital Territory, Australia
- +6 more
Jul 26, 2018